Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katherine M. Cunningham"'
Autor:
Gizem Efe, Katherine M. Cunningham, Qiaosi Tang, Kensuke Sugiura, Karen Dunbar, Kensuke Suzuki, Lois Resnick-Silverman, Alison M. Taylor, James J. Manfredi, Carol L. Prives, Anil K. Rustgi
Publikováno v:
Cancer Research. 83:1289-1289
INTRODUCTION/METHODS: The multistep process of the tumor invasion-metastasis cascade is a major barrier to effective therapy. Mutations of the tumor suppressor p53 are frequently detected in esophageal squamous cell carcinoma (ESCC) cases, which in t
Autor:
Andrew Tumen, Rei Ukita, Kenmond Fung, Jinho Kim, Ya-Wen Chen, Jonathan A. Reimer, Brandon A. Guenthart, Ahmed E. Hozain, Rachel Donocoff, Edward C. Ruiz, Katherine M. Cunningham, Hans-Willem Snoeck, Nancy L. Cardwell, Michael T. Simpson, Dawn Queen, Alexander Romanov, Meghan R. Pinezich, Yuliya Tipograf, Charles C. Marboe, John W. Stokes, Jennifer Talackine, John D. O’Neill, Matthew Bacchetta, Adam Griesemer, Gordana Vunjak-Novakovic
Publikováno v:
Nature Medicine. 26:1102-1113
Patients awaiting lung transplantation face high wait-list mortality, as injury precludes the use of most donor lungs. Although ex vivo lung perfusion (EVLP) is able to recover marginal quality donor lungs, extension of normothermic support beyond 6
Autor:
Gizem Efe, Qiaosi Tang, Katherine M. Cunningham, Kensuke Sugiura, Karen Dunbar, Kausik Regunath, Kensuke Suzuki, Andres J. Klein-Szanto, Lois Resnick-Silverman, James J. Manfredi, Carol L. Prives, Anil K. Rustgi
Publikováno v:
Cancer Research. 83:B014-B014
Introduction: Mutations of the tumor suppressor p53 are detected up to 80% of esophageal squamous cell carcinoma (ESCC) cases, which in turn correlate with high metastatic rates and poor prognosis. To understand the mutant p53-mediated mechanisms in
Autor:
Katherine M. Cunningham, Brandon A. Guenthart, Dawn Queen, Rachel Donocoff, Jinho Kim, John D. O’Neill, Matthew Bacchetta, Ahmed E. Hozain, Gordana Vunjak-Novakovic, Holly M. Wobma, Charles C. Marboe, Michael T. Simpson, Alexander Romanov, Michael Salna, Kenmond Fung, Scott Chicotka, Susan P. Halligan
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Nature Communications
Nature Communications
The number of available donor organs limits lung transplantation, the only lifesaving therapy for the increasing population of patients with end-stage lung disease. A prevalent etiology of injury that renders lungs unacceptable for transplantation is
Autor:
Ahmed E, Hozain, John D, O'Neill, Meghan R, Pinezich, Yuliya, Tipograf, Rachel, Donocoff, Katherine M, Cunningham, Andrew, Tumen, Kenmond, Fung, Rei, Ukita, Michael T, Simpson, Jonathan A, Reimer, Edward C, Ruiz, Dawn, Queen, John W, Stokes, Nancy L, Cardwell, Jennifer, Talackine, Jinho, Kim, Hans-Willem, Snoeck, Ya-Wen, Chen, Alexander, Romanov, Charles C, Marboe, Adam D, Griesemer, Brandon A, Guenthart, Matthew, Bacchetta, Gordana, Vunjak-Novakovic
Publikováno v:
Nature medicine. 26(7)
Patients awaiting lung transplantation face high wait-list mortality, as injury precludes the use of most donor lungs. Although ex vivo lung perfusion (EVLP) is able to recover marginal quality donor lungs, extension of normothermic support beyond 6
Autor:
Ya-Wen Chen, Sarah X.L. Huang, Holly M. Wobma, Matthew Bacchetta, John D. O’Neill, Mauer Biscotti, Katherine M. Cunningham, Brandon A. Guenthart, Gordana Vunjak-Novakovic, Jinho Kim, N. Valerio Dorrello, Hans-Willem Snoeck, Theresa Swayne
Publikováno v:
Science Advances
We propose a new approach to lung regeneration by replacement of damaged epithelium with full preservation of lung vasculature.
End-stage lung disease is the third leading cause of death worldwide, accounting for 400,000 deaths per year in the U
End-stage lung disease is the third leading cause of death worldwide, accounting for 400,000 deaths per year in the U